Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca withdraws COVID-19 vaccine Vaxzevria

az_vaccine
May 9, 2024
Sales and Marketing AstraZeneca, COVID-19, Immunology, thrombosis with thrombocytopenia syndrome

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in …

News
dementia image

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024
Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia

Nxera Pharma’s neuroscience-focused biopharmaceutical partner  Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …

News

Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet

May 8, 2024
Research and Development Hepatology, Mirum Pharmaceuticals, PFIC, The Lancet, clinical trials

Biopharma company Mirum Pharmaceuticals has announced data from its phase 3 MARCH-PFIC study which evaluated maralixibat in patients with progressive …

News
biology-think-networking-physiology-brain-anatomy-2676370

Circular Genomics reveals study results into predicting patient response to SSRI antidepressant treatment

May 8, 2024
Research and Development Circular Genomics, Psychiatry, SSRI, antidepressant treatment, blood assays

US RNA biomarker company Circular Genomics has announced study results highlighting the company’s first blood assay to predict a patient’s …

News
lungs

Gossamer Bio and Chiesi Group enter into international collaboration to commercialise Seralutinib

May 7, 2024
Research and Development Chiesi, Chronic Diseases, Gossamer Bio, PAH, PH-ILD, collaboration

US-based clinical stage biopharma company Gossamer Bio and Italian research-focused biopharma group Chiesi Farmaceutici have entered into an international agreement …

News
trials

Broken String Biosciences and the Francis Crick Institute collaborate on ALS research

May 7, 2024
Research and Development Broken String Biosciences, Francis Crick Institute, Neurology, amyotrophic lateral sclerosis, genomics

Genomics company Broken String Biosciences and biomedical discovery institute Francis Crick have announced a research collaboration, focusing on amyotrophic lateral …

News

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024
Research and Development AbbVie, Pharmacy, R&D, facility

AbbVie has announced that it is investing approximately €150m in its second largest research and development (R&D) facility worldwide. The …

News

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024
Medical Communications AstraZeneca, Calquence, Oncology, clinical trial, lymphoma

AstraZeneca has announced positive high-level results from an interim analysis of the ECHO phase 3 trial, which assessed Calquence (acalabrutinib) …

News

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024
Research and Development Gastric, MSD, Merck, Oncology, keytruda

Merck, known as MSD outside of the US and Canada, has announced data from the phase 3 KEYNOTE-811 trial which …

News

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024
Medical Communications COPD, Cardiology, clinical trial, verona pharma

Verona Pharma has announced that it will share eight posters at the American Thoracic Society International Conference (ATS) 2024, including …

News

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024
Manufacturing and Production Beckman Coulter Life Sciences, DNA, Pharmacy, RNA, Watchmaker Genomics, collaboration

Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim …

News

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024
Research and Development Obesity, Veru, Wegovy, enobosarm, weight loss

Veru has announced that it has enrolled the first patients into its phase 2b clinical trial of enobosarm, an oral …

News

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024
Research and Development Bayer, Cardiology, cardio, cvd

Bayer and Evotec have announced that they have updated the focus of their collaboration to work on the development of …

News

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024
Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides

PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.

News
anirudh-djo3injpaoe-unsplash_3

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024
Medical Communications FDA, Haematology, Pfizer, haemophilia

Pfizer has announced that the US Food and Drug Administration (FDA) has approved Beqvez (fidanacogene elaparvovec-dzkt) for the treatment of …

News

J&J gains positive CHMP opinion for Rybrevant for treatment of lung cancer

April 29, 2024
Medical Communications CHMP, EMA, J&J, Oncology, Rybrevant, lung cancer

Janssen, a Johnson & Johnson (J&J) company, has announced that the Committee for Medicinal Products for Human Use (CHMP) of …

News

Regeneron and Mammoth Biosciences announce CRISPR collaboration

April 26, 2024
Research and Development Pharmacy, Regeneron, crispr, gene editing

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration for the research, development and commercialisation of in vivo CRISPR-based gene …

News

ANGLE signs commercial agreement with AstraZeneca

April 26, 2024
Business Services Angle, AstraZeneca, Pharmacy, commercial agreement

ANGLE has announced that it has signed a supplier agreement with AstraZeneca for the development and validation of a methodology …

News

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024
Research and Development Oncology, Ono Pharmaceutical, Prism BioLab, research and licensing agreement

Prism BioLab has announced that it has entered into a target-exclusive research and licensing agreement with Ono Pharmaceutical. Under the …

News

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024
Medical Communications Ascendis Pharma, Internal Medicine, MHRA, hypoparathyroidism

Ascendis Pharma has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for Yorvipath …

News

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024
Manufacturing and Production Eli Lilly, Nexus Pharmaceuticals, Pharmacy, acquisition, facility

Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement for Eli Lilly to acquire …

News

Latest content

AstraZeneca withdraws COVID-19 vaccine Vaxzevria

May 9, 2024

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024

Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet

May 8, 2024

Circular Genomics reveals study results into predicting patient response to SSRI antidepressant treatment

May 8, 2024

Gossamer Bio and Chiesi Group enter into international collaboration to commercialise Seralutinib

May 7, 2024